197067530	197067530	CD	B-NP	O
|	|	NNP	I-NP	O
RHC	RHC	NNP	I-NP	O
|	|	VBD	B-VP	O
20930664	20930664	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7837798	7837798	CD	B-NP	O
|	|	CC	I-NP	O
11/22/2004	11/22/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/21/2004	5/21/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/23/2004	6/23/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
STETTLER	STETTLER	NN	B-NP	O
,	,	,	O	O
HAL	HAL	NN	B-NP	O
657-85-93-4	657-85-93-4	CD	I-NP	O
Well	Well	NNP	I-NP	O
Spo	Spo	NNP	I-NP	O
Uxsmouth	Uxsmouth	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
5/29/04	5/29/04	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KOLKMAN	KOLKMAN	NNP	B-NP	O
,	,	,	O	O
ISIDRO	ISIDRO	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NN	B-NP	B-protein
200	200	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
MCCRABB	MCCRABB	NNP	B-NP	O
,	,	,	O	O
FREDDY	FREDDY	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
04867472	04867472	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitioring	monitiore	VBG	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
STOCKBRIDGE	STOCKBRIDGE	NN	B-NP	O
,	,	,	O	O
TRENT	TRENT	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
87520532	87520532	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
SCHWEINER	SCHWEINER	NN	B-NP	O
,	,	,	O	O
MICHAL	MICHAL	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
GLIPIZIDE	GLIPIZIDE	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
SAGUIL	SAGUIL	NNP	B-NP	O
,	,	,	O	O
CLAYTON	CLAYTON	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POSSIBLE	POSSIBLE	NNP	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
glyburide	glyburide	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
HOBEREK	HOBEREK	NN	B-NP	B-protein
,	,	,	O	O
JEWELL	JEWELL	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POSSIBLE	POSSIBLE	NNP	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
GUAIFENESIN	GUAIFENESIN	NN	I-NP	O
10	10	CD	I-NP	O
MILLILITERS	MILLILITERS	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/28	3/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Other	Other	NNP	I-NP	O
:	:	:	O	O
cough	cough	IN	B-PP	O
ISORDIL	ISORDIL	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
DINITRATE	DINITRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
110	110	CD	B-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
ho	ho	NN	I-NP	O
if	if	IN	B-SBAR	O
holding	hold	VBG	B-VP	O
SARNA	SARNA	NN	B-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
QD	QD	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
to	to	TO	B-PP	O
lower	low	JJR	B-NP	O
extremities	extremity	NNS	I-NP	O
COUMADIN	COUMADIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QOD	QOD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/28	3/28	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
5mg	5mg	NN	B-NP	O
qod	qod	NN	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
DERENTIS	DERENTIS	NN	B-NP	O
,	,	,	O	O
EDUARDO	EDUARDO	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
HYDROCORTISONE	HYDROCORTISONE	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
-	-	HYPH	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
to	to	TO	B-PP	O
R	R	NN	B-NP	B-protein
elbow	elbow	NN	I-NP	I-protein
eczema	eczema	NN	I-NP	I-protein
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/7	5/7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Administer	Administer	NNP	I-NP	O
iron	iron	NN	I-NP	O
products	product	NNS	I-NP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
DADLANI	DADLANI	NNP	B-NP	O
,	,	,	O	O
DANNY	DANNY	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
04867472	04867472	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitioring	monitiore	VBG	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
WANDS	WANDS	NNP	B-NP	O
,	,	,	O	O
TREY	TREY	NNP	B-NP	O
V.	V.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
87520532	87520532	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/04	4/4/04	CD	B-NP	O
by	by	IN	B-PP	O
DUESTERBACK	DUESTERBACK	NNP	B-NP	O
,	,	,	O	O
CARROL	CARROL	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AMIODARONE	AMIODARONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
84499634	84499634	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOFLOXACIN	LEVOFLOXACIN	NNP	B-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
monitoring	monitor	VBG	B-VP	O
NIZORAL	NIZORAL	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
%	%	NN	I-NP	I-protein
SHAMPOO	SHAMPOO	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	O	O
KETOCONAZOLE	KETOCONAZOLE	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
SHAMPOO	SHAMPOO	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
tiweek	tiweek	NN	I-NP	O
SYNALAR	SYNALAR	NN	I-NP	O
0.025	0.025	CD	B-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
FLUOCINOLONE	FLUOCINOLONE	NN	I-NP	O
0.025	0.025	CD	B-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
`	`	``	O	O
apply	apply	VB	B-VP	O
below	below	IN	B-PP	O
knees	knee	NNS	B-NP	O
on	on	IN	B-PP	O
both	both	DT	B-NP	O
legs	leg	NNS	I-NP	O
.	.	.	O	O

PLAQUENIL	PLAQUENIL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROXYCHLOROQUINE	HYDROXYCHLOROQUINE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	B-DNA
NORVASC	NORVASC	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
AMLODIPINE	AMLODIPINE	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Freed	Freed	NNP	I-NP	O
,	,	,	O	O
Friday	Friday	NNP	B-NP	O
July	July	NNP	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	VBP	B-VP	O
scheduled	scheduled	JJ	B-ADJP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
9/2	9/2	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dewitt	Dewitt	NNP	B-NP	O
Luckhardt	Luckhardt	NNP	I-NP	O
,	,	,	O	O
304-349-2431	304-349-2431	CD	B-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
Sotalol	Sotalol	NN	B-NP	O
,	,	,	O	O
Procainamide	Procainamide	NNP	B-NP	O
,	,	,	O	O
Aspirin	Aspirin	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Quinaglute	Quinaglute	NNP	B-NP	O
,	,	,	O	O
Asa	Asa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
transient	transient	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
attack	attack	NN	I-NP	O
vs	vs	IN	B-PP	O
exacerbation	exacerbation	NN	B-NP	O
of	of	IN	B-PP	O
underlying	underlie	VBG	B-VP	O
neurologic	neurologic	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	B-protein
;	;	:	O	O
CHF	CHF	NN	B-NP	B-protein
;	;	:	O	O
s/p	s/p	NN	B-NP	O
St.	St.	NNP	I-NP	O
Jude	Jude	NNP	I-NP	O
MVR	MVR	NNP	I-NP	O
for	for	IN	B-PP	O
MS	MS	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hx	Hx	NNP	I-NP	O
AFib/flutter	AFib/flutter	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
H/O	H/O	NNP	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
IMI	IMI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hx	Hx	NN	I-NP	O
DVT	DVT	NN	I-NP	O
'70	'70	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
appy	appy	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
sigmoidectomy	sigmoidectomy	NN	I-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
L	L	NN	I-NP	I-protein
hip	hip	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
'95	'95	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
S/P	S/P	NN	I-NP	O
hip	hip	NN	I-NP	O
fracture	fracture	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
PE	PE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
embolism	embolism	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
Mrs.	Mrs.	NNP	B-NP	O
Marnett	Marnett	NNP	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
81	81	CD	I-NP	O
y.o.	y.o.	NN	I-NP	O
woman	woman	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
difficulty	difficulty	NN	B-NP	O
speaking	speaking	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lightheadedness	lightheadedness	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
URI	URI	NN	B-NP	O
symptoms	symptom	NNS	I-NP	O
about	about	IN	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
then	then	RB	O	O
5d	5d	CD	B-NP	O
pta	pta	NN	I-NP	O
developed	develop	VBD	B-VP	O
minimal	minimal	JJ	B-NP	O
ly	ly	RB	I-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
SOB	SOB	NN	B-NP	B-protein
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
2-3	2-3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
noctural	noctural	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
or	or	CC	I-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
number	number	NN	B-NP	O
of	of	IN	B-PP	O
pillows	pillow	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
reverend	reverend	NN	I-NP	O
checks	check	VBZ	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
daily	daily	NN	I-NP	O
;	;	:	O	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
he	he	PRP	B-NP	O
suggested	suggest	VBD	B-VP	O
she	she	PRP	B-NP	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
feel	feel	VB	I-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
any	any	DT	B-NP	O
speech	speech	NN	I-NP	O
difficulties	difficulty	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
awoke	awake	VBD	B-VP	O
she	she	PRP	B-NP	O
noted	note	VBD	B-VP	O
heaviness	heaviness	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
tongue	tongue	NN	I-NP	O
and	and	CC	I-NP	O
workd	workd	NN	I-NP	O
finding	finding	NN	I-NP	O
difficulties	difficulty	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
sweating	sweating	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
radiated	radiate	VBD	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
shoulder	shoulder	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
L	L	NN	I-NP	O
>	>	SYM	B-NP	O
R	R	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
,	,	,	O	O
and	and	CC	O	O
back	back	RB	B-ADVP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
different	different	JJ	B-ADJP	O
than	than	IN	B-PP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
anginal	anginal	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
which	which	WDT	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
involve	involve	VB	I-VP	O
back	back	RB	B-ADVP	O
radiation	radiation	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
pleuritic	pleuritic	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
denied	deny	VBD	B-VP	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
noticed	notice	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
dry	dry	JJ	B-NP	O
heaving	heaving	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
leaving	leave	VBG	B-VP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
``	``	``	O	O
lightheadness	lightheadness	NN	B-NP	O
.	.	.	O	O
''	''	''	O	O

This	This	DT	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
involve	involve	VB	I-VP	O
any	any	DT	B-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
vertigo	vertigo	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
vision	vision	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
sat	sit	VBD	B-VP	O
down	down	IN	B-ADVP	O
immediately	immediately	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
felt	feel	VBD	B-VP	O
better	good	JJR	B-ADJP	O
within	within	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
seconds	second	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
fall	fall	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
LOC	LOC	NN	I-NP	B-protein
.	.	.	O	O

Around	Around	IN	B-PP	O
8am	8am	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
housekeeper	housekeeper	NN	I-NP	O
came	come	VBD	B-VP	O
,	,	,	O	O
and	and	CC	O	O
immediately	immediately	RB	B-VP	O
noticed	notice	VBD	I-VP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
Mrs.	Mrs.	NNP	B-NP	O
Cooney	Cooney	NNP	I-NP	O
's	's	POS	B-NP	O
voice	voice	NN	I-NP	O
.	.	.	O	O

Mrs.	Mrs.	NNP	B-NP	O
Solberg	Solberg	NNP	I-NP	O
describes	describe	VBZ	B-VP	O
the	the	DT	B-NP	O
change	change	NN	I-NP	O
as	as	IN	B-PP	O
a	a	DT	B-NP	O
``	``	``	I-NP	O
thickening	thicken	VBG	I-NP	O
of	of	IN	B-PP	O
my	my	PRP$	B-NP	O
tongue	tongue	NN	I-NP	O
''	''	''	O	O
and	and	CC	O	O
some	some	DT	B-NP	O
problems	problem	NNS	I-NP	O
finding	find	VBG	B-VP	O
words	word	NNS	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
prescribed	prescribe	VBN	B-VP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
,	,	,	O	O
Mrs.	Mrs.	NNP	B-NP	O
Shoman	Shoman	NNP	I-NP	O
noted	note	VBD	B-VP	O
a	a	DT	B-NP	O
raised	raise	VBN	I-NP	O
,	,	,	I-NP	O
painful	painful	JJ	I-NP	O
area	area	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
L	L	NN	I-NP	O
forearm	forearm	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
recall	recall	VB	I-VP	O
any	any	DT	B-NP	O
trauma	trauma	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

PMedHx	PMedHx	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

H/o	H/o	NN	B-NP	O
agina	agina	NN	I-NP	O
-LRB-	-LRB-	:	O	O
a	a	DT	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Echo	Echo	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/3	4/3	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	I-NP	O
EF	EF	NNP	I-NP	O
55	55	CD	I-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
abnormal	abnormal	JJ	B-NP	O
septal	septal	JJ	I-NP	O
motion	motion	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	B-protein
AR	AR	NNS	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
MR	MR	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	O
through	through	IN	B-PP	O
mech	mech	NN	B-NP	O
valve	valve	VBP	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
mod	mod	NN	B-NP	O
TR	TR	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	JJ	B-NP	O
b	b	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Holter	Holter	NNP	I-NP	O
11/21	11/21	CD	I-NP	O
-	-	HYPH	I-NP	O
multiform	multiform	JJ	I-NP	O
VE	VE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
bigem	bigem	NN	I-NP	O
,	,	,	O	O
cooup	cooup	NN	B-NP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
SVE	SVE	NNP	B-NP	O
's	's	POS	B-NP	O
1st	1st	JJ	I-NP	O
degree	degree	NN	I-NP	O
A-V	A-V	NN	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

D.M.	D.M.	NNP	B-NP	O
AGA1c	AGA1c	NN	I-NP	O
6.1	6.1	CD	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
8/24	8/24	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

subacute	subacute	JJ	B-NP	O
thalamic	thalamic	JJ	I-NP	O
stroke	stroke	NN	I-NP	O
noted	note	VBN	B-VP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	B-protein
4/3	4/3	CD	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Afib	Afib	NN	B-NP	O
-	-	:	O	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

Mitral	Mitral	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
-	-	HYPH	B-NP	O
MVR	MVR	NN	I-NP	B-protein
St	St	NNP	I-NP	O
Jude	Jude	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/6	11/6	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
admitted	admit	VBD	B-VP	O
many	many	JJ	B-NP	O
times	time	NNS	I-NP	O
,	,	,	O	O
latest	late	JJS	B-NP	O
5/8	5/8	CD	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Restrictive	Restrictive	JJ	B-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
-	-	HYPH	B-NP	O
3/16	3/16	CD	I-NP	O
PFTs	PFT	NNS	I-NP	O
FVC	FVC	NN	I-NP	O
1.33	1.33	CD	I-NP	O
,	,	,	O	O
FEV1	FEV1	CD	B-NP	O
0.98	0.98	CD	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

Sigmoid	Sigmoid	JJ	B-NP	B-protein
colostomy	colostomy	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Ventral	Ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
Bladder	Bladder	NN	I-NP	O
calcifications	calcification	NNS	I-NP	O
on	on	IN	B-PP	O
CT	CT	NN	B-NP	B-protein
urogram	urogram	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
4/3	4/3	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
-	-	HYPH	B-NP	O
needs	need	VBZ	B-VP	O
cystoscopy	cystoscopy	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
.	.	.	O	O

RA	RA	NN	B-NP	B-protein
13	13	CD	I-NP	I-protein
.	.	.	O	O

Recent	Recent	JJ	B-NP	O
eye	eye	NN	I-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
.	.	.	O	O

Physical	Physical	NNP	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T	T	NN	B-NP	O
98.9	98.9	CD	I-NP	O
P	P	NN	I-NP	B-protein
103	103	CD	B-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	B-DNA
160/74	160/74	CD	I-NP	I-DNA
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
20	20	CD	I-NP	I-protein
,	,	,	O	O
OxySat	OxySat	NNP	B-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
NC	NC	NN	I-NP	O
,	,	,	O	O
FSG	FSG	NN	B-NP	O
172	172	CD	I-NP	O
Gen	Gen	NNP	I-NP	O
:	:	:	O	O
soft	soft	JJ	B-NP	O
voice	voice	NN	I-NP	O
,	,	,	O	O
audible	audible	JJ	B-NP	O
clicking	clicking	NN	I-NP	O
sound	sound	NN	I-NP	O
,	,	,	O	O
NAD	NAD	NN	B-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
Card	Card	NNP	I-NP	O
:	:	:	O	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
S1	S1	NN	I-NP	B-protein
,	,	,	O	O
mechanical	mechanical	JJ	B-NP	O
S2	S2	NN	I-NP	O
,	,	,	O	O
II/VI	II/VI	NN	B-NP	O
early	early	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
loudest	loud	JJS	B-ADVP	O
at	at	IN	B-PP	O
base	base	NN	B-NP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
reduced	reduce	VBN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	NNS	I-NP	O
at	at	IN	B-PP	O
dependant	dependant	JJ	B-NP	O
1/3	1/3	CD	I-NP	O
b/l	b/l	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
wheezes	wheeze	VBZ	B-VP	O
heard	heard	NN	B-NP	O
.	.	.	O	O

Abd	Abd	NN	B-NP	O
:	:	:	O	O
well	well	RB	B-ADVP	O
healed	heal	VBD	B-VP	O
midline	midline	NN	B-NP	O
scars	scar	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
ascultated	ascultate	VBN	B-VP	O
,	,	,	O	O
+	+	SYM	O	O
BS	BS	NNP	B-NP	O
.	.	.	O	O

Soft	Soft	RB	B-ADVP	O
,	,	,	O	O
NT	NT	NN	B-NP	O
,	,	,	O	O
ND	ND	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Integ	Integ	NNP	B-NP	O
:	:	:	O	O
diffuse	diffuse	JJ	B-NP	O
macular	macular	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
5-10mm	5-10mm	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hyperpigmented	hyperpigmente	VBD	B-VP	O
rash	rash	NN	B-NP	O
distal	distal	JJ	B-ADJP	O
to	to	TO	B-PP	O
knees	knee	NNS	B-NP	O
b/l	b/l	NN	I-NP	O
.	.	.	O	O

Ext	Ext	NN	B-NP	O
:	:	:	O	O
2x3	2x3	CD	B-NP	O
cm	cm	NN	I-NP	O
raised	raise	VBD	B-VP	O
tender	tender	NN	B-NP	O
area	area	NN	I-NP	O
on	on	IN	B-PP	O
L	L	NN	B-NP	O
forearm	forearm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
skin	skin	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

<	<	SYM	O	O
3	3	CD	B-NP	O
s	s	NN	I-NP	O
cap	cap	NN	I-NP	O
refill	refill	NN	I-NP	O
L	L	NN	I-NP	O
hand	hand	NN	I-NP	O
.	.	.	O	O

Full	Full	JJ	B-NP	O
ROM	ROM	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	B-protein
fingers	finger	NNS	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
pain	pain	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
PT	PT	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
b/l	b/l	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
radial/ulnar	radial/ulnar	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
b/l	b/l	NN	B-NP	O
Neuro	Neuro	NNP	I-NP	O
:	:	:	O	O
A	A	NNP	B-NP	O
&	&	CC	I-NP	O
O	O	NNP	I-NP	O
x	x	NNP	I-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
attentive	attentive	JJ	B-NP	O
,	,	,	I-NP	O
cooperative.Naming	cooperative.Naming	NN	I-NP	O
intact	intact	JJ	I-NP	O
,	,	,	O	O
follows	follow	VBZ	B-VP	O
commands	command	NNS	B-NP	O
,	,	,	O	O
repetition	repetition	NN	B-NP	O
intact	intact	JJ	I-NP	O
,	,	,	I-NP	O
fluent	fluent	JJ	I-NP	O
English	English	JJ	I-NP	O
CN	CN	NN	I-NP	O
2-12	2-12	NN	I-NP	O
:	:	:	O	O
reactive	reactive	JJ	B-NP	O
pupils	pupil	NNS	I-NP	O
,	,	,	O	O
Eomi	Eomi	NN	B-NP	B-protein
,	,	,	O	O
sensation	sensation	NN	B-NP	O
intact	intact	JJ	B-ADJP	O
throughout	throughout	IN	B-ADVP	O
,	,	,	O	O
hearing	hear	VBG	B-VP	O
intact	intact	JJ	B-ADJP	O
to	to	TO	B-VP	O
finger	finger	VB	I-VP	O
rub	rub	NN	B-NP	O
,	,	,	O	O
palate	palate	NN	B-NP	O
elevates	elevate	NNS	I-NP	O
,	,	,	O	O
tongue	tongue	NN	B-NP	O
midline	midline	NN	I-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
strength	strength	NN	I-NP	O
trap	trap	NN	I-NP	O
and	and	CC	I-NP	O
SCM	SCM	NN	I-NP	O
.	.	.	O	O

Face	Face	NNP	B-NP	O
symmetric	symmetric	JJ	I-NP	O
Motor	Motor	NNP	I-NP	O
:	:	:	O	O
Strength	Strength	NNP	B-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
arm	arm	NN	I-NP	O
:	:	:	O	O
5/5	5/5	CD	B-NP	O
Del/Bi/Tri	Del/Bi/Tri	NNP	I-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
arm	arm	VBP	B-VP	O
4/5	4/5	CD	B-NP	O
with	with	IN	B-PP	O
giveway	giveway	NN	B-NP	B-protein
character	character	NN	I-NP	I-protein
Del/Bi/Tri	Del/Bi/Tri	NNP	I-NP	I-protein
L	L	NNP	I-NP	I-protein
leg	leg	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
-	-	HYPH	O	O
/	/	SYM	O	B-protein
5	5	CD	B-NP	I-protein
HF	HF	NN	I-NP	I-protein
5/5	5/5	CD	B-NP	I-protein
KE/PF/DF	KE/PF/DF	NNP	I-NP	I-protein
R	R	NNP	I-NP	I-protein
leg	leg	NN	I-NP	I-protein
5/5	5/5	CD	I-NP	I-protein
HF/KE/PF	HF/KE/PF	NN	I-NP	I-protein
/	/	SYM	B-NP	O
DFTone	DFTone	NN	I-NP	O
:	:	:	O	O
normalCoordination	normalCoordination	NN	B-NP	O
:	:	:	O	O
FNF	FNF	NN	B-NP	O
normal	normal	JJ	I-NP	O
b/l	b/l	NN	I-NP	O
,	,	,	O	O
heel-shin	heel-shin	JJ	B-NP	O
R	R	NN	I-NP	O
leg	leg	NN	I-NP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
effort	effort	NN	B-NP	O
limited	limit	VBD	B-VP	O
L	L	NN	B-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

Gait	Gait	NNP	B-NP	O
:	:	:	O	O
not	not	RB	O	O
assessed	assess	VBN	B-VP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
by	by	IN	B-PP	O
system	system	NN	B-NP	O
:	:	:	O	O
Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
Speech	Speech	NN	B-NP	O
difficulties	difficulty	NNS	I-NP	O
:	:	:	O	O
resolved	resolve	VBN	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
,	,	,	O	O
making	make	VBG	B-VP	O
diagnosis	diagnosis	NN	B-NP	O
difficult	difficult	JJ	B-ADJP	O
.	.	.	O	O

Possible	Possible	JJ	B-NP	O
etiologies	etiology	NNS	I-NP	O
include	include	VBP	B-VP	O
TIA	TIA	NN	B-NP	B-protein
or	or	CC	I-NP	O
illness	illness	NN	I-NP	O
exacerbating	exacerbating	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
from	from	IN	B-PP	O
old	old	JJ	B-NP	O
stroke	stroke	NN	I-NP	O
.	.	.	O	O

Head	Head	JJ	B-NP	O
CT	CT	NN	I-NP	O
in	in	IN	B-PP	O
ER	ER	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
old	old	JJ	B-NP	O
infarcts	infarct	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
speech	speech	NN	I-NP	O
difficulties	difficulty	NNS	I-NP	O
throughout	throughout	IN	B-PP	O
admission	admission	NN	B-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
neurologic	neurologic	JJ	I-NP	O
findings	finding	NNS	I-NP	O
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
ischemia	ischemia	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
,	,	,	O	O
one	one	CD	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
low	low	JJ	I-NP	O
probability	probability	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
were	be	VBD	B-VP	O
drawn	draw	VBN	I-VP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
normotensive	normotensive	JJ	B-ADJP	O
even	even	RB	B-SBAR	O
after	after	IN	I-SBAR	O
d/c	d/c	NN	B-NP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	B-protein
HTN	HTN	NN	I-NP	I-protein
meds	med	NNS	I-NP	I-protein
-LRB-	-LRB-	WDT	B-NP	I-protein
see	see	VBP	B-VP	O
renal	renal	JJ	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
for	for	IN	B-PP	O
first	first	JJ	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
alternated	alternate	VBN	B-VP	O
between	between	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
and	and	CC	I-NP	O
afib	afib	NN	I-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
:	:	:	O	O
PNA	PNA	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
left	leave	VBN	I-VP	O
lower	low	JJR	B-NP	O
lobe	lobe	NN	I-NP	O
opacity	opacity	NN	I-NP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
.	.	.	O	O

Decision	Decision	NN	B-NP	O
was	be	VBD	B-VP	O
made	make	VBN	I-VP	O
to	to	TO	B-VP	O
start	start	VB	I-VP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	B-protein
d-dimer	d-dimer	NN	I-NP	I-protein
,	,	,	O	O
but	but	CC	O	O
PE	PE	NN	B-NP	O
was	be	VBD	B-VP	O
very	very	RB	B-ADJP	O
unlikely	unlikely	JJ	I-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalizaiton	hospitalizaiton	NN	I-NP	O
although	although	IN	B-SBAR	O
her	her	PRP$	B-NP	O
cxr	cxr	NN	I-NP	B-protein
was	be	VBD	B-VP	O
read	read	VBN	I-VP	O
as	as	IN	B-PP	O
mild	mild	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
ARF	ARF	NN	B-NP	B-protein
:	:	:	O	O
Creatine	Creatine	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
,	,	,	O	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
1.2-1	1.2-1	CD	B-NP	O
.3	.3	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
her	her	PRP$	B-NP	O
h/o	h/o	NN	I-NP	O
poor	poor	JJ	I-NP	O
po	po	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	O	O
euvolemic	euvolemic	JJ	B-ADJP	O
to	to	TO	B-PP	O
dry	dry	JJ	B-NP	O
exam	exam	NN	I-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
prerenal	prerenal	JJ	B-NP	O
hypovolemia	hypovolemia	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
and	and	CC	I-NP	O
colchicine	colchicine	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
they	they	PRP	B-NP	O
might	might	MD	B-VP	O
contribute	contribute	VB	I-VP	O
to	to	TO	B-PP	O
further	further	JJ	B-NP	O
ARF	ARF	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	B-protein
got	get	VBD	B-VP	I-protein
gentle	gentle	JJ	B-NP	I-protein
ivf	ivf	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
approximately	approximately	RB	B-NP	O
1L	1L	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improved	improve	VBD	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
after	after	IN	B-PP	O
restarting	restart	VBG	B-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
her	her	PRP$	B-NP	O
Cr	Cr	NN	I-NP	B-protein
again	again	RB	B-VP	O
bumped	bump	VBN	I-VP	O
to	to	TO	B-PP	O
1.8	1.8	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
UA	UA	NN	I-NP	O
was	be	VBD	B-VP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
home	home	NN	I-NP	O
off	off	IN	B-PP	O
lasix	lasix	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
and	and	CC	O	O
colchicine	colchicine	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Cr	Cr	NN	I-NP	O
of	of	IN	B-PP	O
1.8	1.8	CD	B-NP	O
presuming	presume	VBG	B-VP	O
that	that	IN	B-SBAR	O
sh	sh	NN	B-NP	O
e	e	NN	I-NP	O
was	be	VBD	B-VP	O
still	still	RB	B-ADVP	O
prerenal	prerenal	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
plan	plan	NN	I-NP	O
is	be	VBZ	B-VP	O
for	for	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
to	to	TO	B-VP	O
check	check	VB	I-VP	O
her	her	PRP$	B-NP	O
chem7	chem7	NN	I-NP	O
in	in	IN	B-PP	O
3days	3day	NNS	B-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
results	result	VBZ	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Skibo	Skibo	NNP	I-NP	O
for	for	IN	B-PP	O
monitoring	monitor	VBG	B-VP	O
and	and	CC	I-VP	O
deciding	decide	VBG	I-VP	O
when	when	WRB	B-ADVP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

MSK	MSK	NN	B-NP	B-protein
:	:	:	O	O
Pt	Pt	NN	B-NP	O
developed	develop	VBD	B-VP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
forearm	forearm	NN	I-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	I-NP	O
pain	pain	NN	I-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hosp	hosp	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
night	night	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
radiograph	radiograph	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
fracture	fracture	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
remitted	remit	VBN	B-VP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
dull	dull	JJ	I-NP	O
ache	ache	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
swelling	swelling	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
Anticoagulation	Anticoagulation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
INR	INR	NN	B-NP	B-protein
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
theraputic	theraputic	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
closely	closely	RB	I-VP	O
monitored	monitor	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
3	3	CD	B-NP	O
after	after	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
checked	check	VBN	I-VP	O
again	again	RB	B-ADVP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
3	3	CD	B-NP	I-protein
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
results	result	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Sheldon	Sheldon	NNP	B-NP	O
Dingmann	Dingmann	NNP	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
D.M.	D.M.	NNP	B-NP	O
Pt	Pt	NNP	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
from	from	IN	B-PP	O
micronase	micronase	NN	B-NP	B-protein
to	to	TO	B-VP	O
glipizide	glipizide	VB	I-VP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
worsening	worsen	VBG	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

Fingersticks	Fingerstick	NNS	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
acceptable	acceptable	JJ	B-NP	O
range	range	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
100-148	100-148	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
during	during	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Dispo	Dispo	NNP	B-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
home	home	VB	I-VP	O
with	with	IN	B-PP	O
close	close	JJ	B-NP	O
VNA	VNA	NN	I-NP	O
followup	followup	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
daily	daily	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
weight	weight	NN	B-NP	O
and	and	CC	I-NP	O
BP	BP	NN	I-NP	O
checked	check	VBD	B-VP	O
qd	qd	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
Chem-7	Chem-7	NN	B-NP	B-protein
and	and	CC	I-NP	O
INR	INR	NN	I-NP	B-protein
drawn	draw	VBN	B-VP	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
and	and	CC	I-NP	O
Monday	Monday	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Benamati	Benamati	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TERT	TERT	NNP	I-NP	O
VALLEY	VALLEY	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
finish	finish	VB	I-VP	O
6	6	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
Levo	Levo	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
total	total	NN	I-NP	O
10	10	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
,	,	,	O	O
become	become	VBN	B-VP	O
short	short	JJ	B-ADJP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
have	have	VBP	B-VP	O
increasing	increase	VBG	I-VP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
that	that	WDT	B-NP	O
concern	concern	VBP	B-VP	O
you	you	PRP	B-NP	O
,	,	,	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
visiting	visit	VBG	I-NP	O
nurse	nurse	NN	I-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
important	important	JJ	I-NP	O
followup	followup	NN	I-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
hospitalization.Your	hospitalization.Your	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
medication	medication	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
glipizide	glipizide	NN	B-NP	O
-	-	HYPH	B-NP	O
stop	stop	NN	I-NP	O
taking	take	VBG	B-VP	O
the	the	DT	B-NP	O
micronase	micronase	NN	I-NP	B-protein
.	.	.	O	O

Your	Your	PRP$	B-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	I-NP	O
lisinopril	lisinopril	NN	I-NP	O
and	and	CC	I-NP	O
colchicine	colchicine	NN	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
stopped	stop	VBN	I-VP	O
,	,	,	O	O
do	do	VBP	B-VP	O
n't	n't	RB	I-VP	O
restart	restart	VB	I-VP	O
them	them	PRP	B-NP	O
until	until	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Schoville	Schoville	NNP	I-NP	O
tells	tell	VBZ	B-VP	O
you	you	PRP	B-NP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
othe	othe	JJ	I-NP	O
medications	medication	NNS	I-NP	O
are	be	VBP	B-VP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
.	.	.	O	O

Weigh	Weigh	VB	B-VP	O
yourself	yourself	PRP	B-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
if	if	IN	B-SBAR	O
your	your	PRP$	B-NP	O
weight	weight	NN	I-NP	O
increa	increa	NN	I-NP	O
ses	se	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
2lbs	2lb	NNS	I-NP	B-protein
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
call	call	VBP	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Szesterniak	Szesterniak	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	B-protein
will	will	MD	B-VP	O
check	check	VB	I-VP	O
BP	BP	NN	B-NP	O
and	and	CC	I-NP	O
weight	weight	NN	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Any	Any	DT	B-NP	O
BP	BP	NN	I-NP	B-protein
>	>	JJR	B-NP	O
140/90	140/90	CD	I-NP	O
or	or	CC	O	O
wt	wt	NN	B-NP	O
gain	gain	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
lbs	lb	NNS	I-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kempf	Kempf	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BROTHERSCIAL	BROTHERSCIAL	NNP	I-NP	O
GITER	GITER	NNP	I-NP	O
HEALTHCARE	HEALTHCARE	NN	I-NP	O
OF	OF	IN	B-PP	O
703-958-5135	703-958-5135	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Thursday	Thursday	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
20	20	CD	I-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
Mon	Mon	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1	1	CD	I-NP	O
of	of	IN	B-PP	O
April	April	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
VNA	VNA	NNP	I-NP	O
will	will	MD	B-VP	O
draw	draw	VB	I-VP	O
a	a	DT	B-NP	O
Chem-7	Chem-7	NN	I-NP	B-protein
and	and	CC	I-NP	O
INR	INR	NN	I-NP	B-protein
and	and	CC	O	O
call	call	VB	B-VP	O
results	result	NNS	B-NP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Maria	Maria	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WA	WA	NNP	I-NP	O
ASSPUNX	ASSPUNX	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
;	;	:	O	O
INR	INR	NN	B-NP	B-protein
should	should	MD	B-VP	O
be	be	VB	I-VP	O
communicated	communicate	VBN	I-VP	O
to	to	TO	B-PP	O
Blaine	Blaine	NNP	B-NP	O
Lindquist	Lindquist	NNP	I-NP	O
at	at	IN	B-PP	O
731-463-2245	731-463-2245	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
followup	followup	NN	B-NP	O
appointment	appointment	NN	I-NP	O
on	on	IN	B-PP	O
8	8	CD	B-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Speranza	Speranza	NNP	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
are	be	VBP	B-VP	O
6	6	CD	B-NP	O
more	more	JJR	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
Levofloxacin	Levofloxacin	NN	B-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BIRES	BIRES	NNP	B-NP	O
,	,	,	O	O
LESLEY	LESLEY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GW792	GW792	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5/29/04	5/29/04	CD	I-NP	O
@	@	SYM	B-NP	O
05	05	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

